Compound 13, a topoisomerase I inhibitor 10, selectively inhibits leishmanial topoisomerase IB and exhibits antileishmanial activity. Specifically, it demonstrates efficacy against L. donovani promastigotes with an IC50 value of 27.91 µM [1].
Target:
Topoisomerase
* VAT and and shipping costs not included. Errors and price changes excepted
